The specific binding of [ 3 Hlclonidine to a,-adrenoceptors on neural membranes isolated from six brain areas was determined with rats treated for various periods of time with the muscarinic agonists, oxotremorine or pilocarpine, or with the muscarinic antagonists atropine, atropine methyl nitrate, scopolamine and scopolamine methyl bromide. Administration of pilocarpine, 10 mg/kg, twice daily i.p. for 1 and 14 days increased markedly the number of a,-adrenoceptors on neural membranes from all six brain areas. In contrast, oxotremorine, 0.3 mg/kg, twice daily i.p., for 7 days decreased the number of a,-adrenoceptors on membranes from all brain areas except the brainstem and caudate nucleus. Both atropine and scopolamine increased the density of a,-adrenoceptors in specific brain areas. Neither atropine methyl nitrate nor scopolamine methyl bromide had an appreciable effect upon the specific binding of [ 3 Hlclonidine to neural membranes from most brain areas. 
Introduction
Recently, long-term treatment of rats with various cholinesterase inhibitors was found to increase markedly the density of a,-adrenoceptors in various areas of the brain as determined by measuring the specific binding of [ 3H]clonidine to neutral membranes (Hollingsworth, 1988) . The presynaptic a,-adrenoceptor plays an important role in the regulation of noradrenaline release from neurons (Langer, 1981; Starke, 1981 agonists and antagonists might modify a,-adrenoceptors in the rat brain has not been evaluated previously.
Oxotremorine, the active metabolite of tremorine, and pilocarpine are cholinergic agonists or partial agonists which have actions within the central nervous system that are blocked by centrally acting muscarinic receptor antagonists (Cho et al., 1962; Cho and Jenden, 1964; Janssen and Niemegeers, 1967) . The purpose of the present study was to determine whether short-or long-term administration of pilocarpine and oxotremorine might influence neuronal function by modifying the number and/or affinity of a,-adrenoceptors in the rat brain in a manner similar to that seen after chronic treatment with cholinesterase inhibitors. In addition, the effects of short-and longterm administration of the centrally acting muscarinic antagonists, atropine and scopolamine, and of their peripherally acting quaternary derivatives, atropine methyl nitrate and scopolamine methyl bromide, were evaluated. 
Materials and methods
Groups of 6 male, Sprague-Dawley rats, 170-230 g, were injected intraperitoneally with saline or with various muscarinic agonists and antagonists for 1,7 or 14 days. The duration of treatment with any specific drug was determined by the ability of the animals to tolerate the drug. Twelve hours after the last injection, the rats were sacrificed by decapitation, their brains removed rapidly and placed in ice-cold Krebs physiological buffer solution and subsequently dissected according to a modification of the method described by Glowinski and Iversen (1966) . The Krebs buffer consisted of (mM): NaCl118; KC1 4.8; CaCl, 1.3; KH,PO, 1.2; MgSO, 1.2; NaHCO, 25; disodium EDTA 0.03; glucose 10; ascorbic acid 0.06. The following regions were studied: hippocampus, amygdala, hypothalamus, parietal-occipital cortex, caudate nucleus, and an area of the brainstem which contained the locus coeruleus.
Measurement of specific binding of [3H]clonidine to neural membranes in rat brain homogenates
The specific binding of [ 3H]clonidine to (Yeadrenoceptors in homogenates was measured as follows. Tissues pooled from the six rats were homogenized in 5 ml of ice-cold Tris-sucrose buffer (Tris-HCl, 5 mM; sucrose, 250 mM; MgCl,, 1 mM; pH 7.4). The homogenates were centrifuged at 1100 X g for 10 min, and the supernatants were saved. The supernatants were next centrifuged at 40000 X g for 10 min, and the pellet saved. The pellet was washed twice with 2 ml of fresh incubation buffer (Tris-HCl, 40 mM; MgCl,, 10 mM; pH 7.5) and recentrifuged at 40000 X g for 10 min. were terminated by rapid filtration under vacuum through Whatman GF/C glass fiber filters and by washing with two 10 ml aliquots of Tris-incubation buffer (25 o C). After termination of the incubation, the glass fiber filters were air dried and then placed in glass scintillation vials and counted for radioactivity as described by Smith et al. (1972) . Protein determinations were performed by the method of Lowry et al. (1951) 
Effects of muscarinic agonists
Treatment of rats with pilocarpine hydrochloride, 10 mg/kg i.p., twice daily for 14 days increased significantly the binding of [ 3 Hlclonidine to neural membranes isolated from all areas of the rat brain studied (table 1). The largest increases occurred with membranes isolated from the amygdala (+ 122%, P -C 0.02) and brainstem (+ 128%, P < 0.001). Intermediate increases occurred with membranes from the hypothalamus (80%, P < O.OOOS), the parietal cortex (+77%, P < 0.005) and the hippocampus (+53%, P < 0.05). The smallest increase occurred with membranes from the caudate nucleus ( + 37%, P < 0.05). 4.61 f 1.50 a P < 0.05, b P -z 0.02, ' P < 0.01, d P < 0.005, e P i 0.001, ' P < 0.0005. Binding parameters were estimated by use of the non-linear curve-fitting program, LIGAND (Munson and Rodbard, 1980) . Animals were treated with pilocarpine hydrochloride, 10 mg/kg i.p., twice daily for either 1 or 14 days. Each point represents the mean 5 S.E. of 3-4 determinations. Short-term treatment of rats with pilocarpine (f 108, P -C 0.0005) and amygdala (+86%, P < hydrochloride, 10 mg/kg i.p., twice daily for 1 day 0.05). Intermediate increases occurred with memalso increased significantly the binding of branes from the hippocampus (54%, P < 0.05) and [ 3 Hlclonidine to neural membranes isolated from the parietal cortex (+ 55%, P -L 0.002). The smalall areas of the rat brain (table 1). The largest lest increase occurred with membranes from the increases occurred with membranes isolated from caudate nucleus (+45%, P < 0.01). Neither shortthe brainstem (+ 115%, P < O.OOl), hypothalamus nor long-term treatment of treatment of rats with 
Discussion
Previously, the chronic administration of cholinesterase inhibitors, neostigmine, triorthocresyl phosphate (TOCP), diisopropylfluorophosphate (DFP) and paraoxon, was found to increase markedly the density of a,-adrenoceptors in various areas of the rat brain (Hollingsworth, 1988) . , 1980) . Animals were treated with atropine methyl nitrate, 3 mg/kg i.p., twice daily for either 1 or 14 days. Each point represents the mean f S.E. of 5-7 determinations.
In the present study, similar increases in the density of qadrenoceptors in specific areas of the rat brain were found after both acute (1 day) and chronic (14 days) treatment of rats with pilocarpine, a muscarinic agonist with pronounced cholinergic activity both within and outside of the central nervous system. The magnitude of the increases in receptor density and the distribution of the receptors in the brain which were affected were very similar to those seen after long-term administration of cholinesterase inhibitors. The observations with pilocarpine would suggest that the changes in qadrenoceptor density in the rat brain after long-term administration of cholinesterase inhibitors were due to stimulation of muscarinic cholinergic receptors. In contrast, the administration of oxotremorine for 7 days resulted in marked decreases in (Yeadrenoceptor density in all brain areas studied except the brainstem.
Oxotremorine presumably produces its characteristic tremor by a mechanism which involves an action of catecholamines upon P-adrenoceptors in the rat brain (Hallberg and Almgren, 1987) . It is possible that the changes in qadrenoceptor number seen in the present study are secondary to increases in the synaptic content of catecholamines within the brain. Oxotremorine has been shown to deplete brain noradrenaline stores in rats (Rogers and Slater, 1971 ) increase brain noradrenaline turnover in rats (Corrodi et al., 1967) and increase brain dopamine turnover in rats (Nose and Takemoto, 1974) and cats (Laverty and Sharman, 1965) . Also, oxotremorine increases markedly plasma catecholamine content when administered to rats (Weinstock et al., 1978 (Weinstock et al., , 1980 . Long-term administration of other drugs, such as the tricyclic antidepressants, which are thought to increase synaptic catecholamine content in the brain, also decreased the specific binding of [3H] clonidine to a,-adrenoceptors in the same brain areas as those affected by oxotremorine (Smith et al., 1981; Smith and Hollingsworth, 1983; 1984) . Thus, the changes in the density of a,-adrenoceptors in rat brain after long-term oxotremorine administration might reflect sustained increases in synaptic catecholamine content.
Differences in efficacy in stimulation of muscarinic receptors or in selectivity for various types of muscarinic receptors might explain the differing effects of the two muscarinic agonists, oxotremorine and pilocarpine, upon the density of a,-adrenoceptors in various areas of the rat brain. Pilocarpine has relatively low efficacy upon presynaptic muscarinic receptors on noradrenergic neurons in the rabbit iris (Bognar et al., 1988 ) similar to that reported for gastrointestinal smooth muscle (Furchgott and Bursztyn, 1967) . Both oxotremorine and pilocarpine are partial agonists upon muscarinic receptors which stimulate phosphoinositol turnover in rat cerebral cortical membranes (Fisher et al., 1983; Freedman et al., 1988 (Freedman et al., 1988) . These results were interpreted to indicate that the receptor selectivity of oxotremorine differed from that of pilocarpine.
Thus, although differences in agonist efficacy might explain the difference between oxotremorine and pilocarpine observed in the present study, differences in receptor selectivity might also be a factor. Considerable evidence exits that there are more than one type of muscarinic receptor in the nervous system (Hammer et al., 1980; Watson et al., 1983; Luthin and Wolfe, 1984; Evans et al., 1985) . In the isolated guinea-pig ileal preparation pilocarpine appears to stimulate a population of muscarinic receptors which differs from that stimulated by oxotremorine. Pilocarpine has been found to enhance the release of acetylcholine from neurons in the guinea-pig myenteric plexus whereas oxotremorine inhibited acetylcholine release from this preparation (Kilbinger, 1984; Kilbinger and Wagner, 1975) . Kilbinger (1984) has speculated that there are two types of presynaptic neuronal muscarinic receptors, one which is stimulated by pilocarpine to enhance neurotransmitter release and the other which is stimulated by oxotremorine to inhibit neurotransmitter release. It is possible that similar differences in selectivity for muscarinic receptors in the central nervous system could be responsible for the differences between the changes in a,-adrenoceptor density caused by pilocarpine and those caused by oxotremorine.
In general, administration for 14 days of the centrally active muscarinic antagonists, atropine sulfate and scopolamine hydrobromide, produced changes in a,-adrenoceptor density similar to those seen with administration of pilocarpine for 1 or 14 days, and opposite to those seen with administration of oxotremorine for 7 days. The increases in receptor density seen with atropine sulfate and scopolamine hydrobromide appear to be mediated through an action within the central nervous system since neither of their quaternary derivatives, which do not readily penetrate the central nervous system, produced similar results when administered chronically.
The results of the present study suggest that atropine and scopolamine might block the actions of endogenous acetylcholine at muscarinic receptors preferentially stimulated by oxotremorine rather than those preferentially stimulated by pilocarpine.
The possibility that these muscarinic antagonists interact directly with a,-adrenoceptors must be considered.
A number of studies have shown that certain muscarinic antagonists possess significant affinity for a,-adrenoceptors (Cantor et al., 1983; Varma and Yue, 1986) . However, the present study confirms the findings of Varma and Yue (1986) that neither scopolamine nor atropine have significant affinity for a,-adrenoceptors in rat brain. The present study shows that muscarinic receptor stimulation and blockade result in appreciable changes in the density of a,-adrenoceptors in various areas of the rat brain. Furthermore, it suggests that muscarinic receptor subtypes preferentially stimulated by either pilocarpine or by oxotremorine or differences in relative efficacy of muscarinic agonists might be factors related to these changes in receptor number. Whether the changes in (Yeadrenoceptor density represent changes in presynaptic or postsynaptic a,-adrenoceptors and the functional significance of such changes remain to be determined.
